US 7081457
Cyclothiocarbamate derivatives as progesterone receptor modulators
granted A61KA61K31/536A61K31/538
Quick answer
US patent 7081457 (Cyclothiocarbamate derivatives as progesterone receptor modulators) held by Ligand Pharmaceuticals Incorporated expires Mon Jul 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ligand Pharmaceuticals Incorporated
- Grant date
- Tue Jul 25 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/536, A61K31/538, A61P, A61P15/00